Doxycycline PEP and 4CMenB as a Comprehensive Prevention Strategy in MSM and TGW at High Risk for Bacterial STIs Within the Swiss HIV Cohort Study
Conditions: Doxycycline STI PEP Sponsors: University of Zurich; Swiss HIV Cohort Study Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Robot-Assisted Gait Training in Early-Subacute Stroke
Conditions: Stroke Interventions: Device: The Lokomat (Hocoma, Zurich, Switzerland). Sponsors: University of Winchester; University Hospitals Dorset NHS Foundation Trust; Hampshire Hospitals NHS Foundation Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Clinical Validation of Novel Malaria Diagnostic Tools for POC Point-of-Care Testing
Conditions: Malaria; Diagnoses Disease; RDT Sponsors: Foundation for Innovative New Diagnostics, Switzerland; Australian Government Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma
Conditions: Glaucoma Sponsors: Swiss Glaucoma Research Foundation Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
PLUS-IS-LESS project: Procalcitonin and Lung UltraSonography-based antibiotherapy in patients with Lower rESpiratory tract infection in Swiss Emergency Departments: study protocol for a pragmatic stepped-wedge cluster-randomized trial
This study was registered on July 19, 2022, on the ClinicalTrials.gov registry using reference number: NCT05463406.Trial statusRecruitment started on December 5, 2022, and will be completed on November 3, 2024. Current protocol version is version 3.0, dated April 3, 2023. (Source: Trials)
Source: Trials - January 25, 2024 Category: Research Source Type: clinical trials
Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts.
Conditions: Warts; Plantar Wart; Common Wart Interventions: Device: S érum VERRUPRO Sponsors: Swiss Footcare Laboratories - Poderm Professional Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
Comparison of Self-collection Using Dry Compared to Wet Swabs for HPV Detection
Conditions: Human Papillomavirus Infection Interventions: Device: • COPAN Self-collection FLOQSwabs® (COPAN, Italy) Sponsors: Foundation for Innovative New Diagnostics, Switzerland; Kenya Medical Research Institute; Frere Hospital, East London, South Africa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation With Conduction System Pacing in Heart Failure
Conditions: Atrial Fibrillation, Persistent; Heart Failure Interventions: Device: Conduction system pacing; Procedure: Atrioventricular nodal ablation; Procedure: Atrial fibrillation ablation Sponsors: University Hospital, Geneva; Swiss National Science Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Follow-up Assessment of a Randomized Controlled Trial of Open-label Placebos for Women With Premenstrual Syndrome
Conditions: Premenstrual Syndrome Interventions: Other: Online Assessment Sponsors: University Hospital, Basel, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials
Effects of Maximum Strength and Acceleration Ability on Performance and Training in Wheelchair Sports
Conditions: Spinal Cord Injuries; Athletes; Wheelchair Sponsors: Swiss Paraplegic Research, Nottwil Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Nephrospec Switzerland
Conditions: Chronic Kidney Diseases; Hypertension Interventions: Device: NephrospecTM, low-intensity extracorporal shockwave therapy device; Device: Sham-Device Sponsors: Menno Pruijm Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
Comparing Stationary and Mobile Ergospirometry
Conditions: Athletes Interventions: Diagnostic Test: Ergometric test Sponsors: Swiss Paraplegic Research, Nottwil Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
Implementation of a New Model of Care for Supporting Long-term Medication Adherence
Conditions: Medication Initiation for Long-term Conditions Interventions: Behavioral: myCare Start Sponsors: University of Geneva, Switzerland; University of Basel; Fundaci ó Sant Joan de Déu; pharmaSuisse, Switzerland; Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland; University of Bern Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
SwissGut - The Healthy Swiss Microbiome
Conditions: Healthy Sponsors: Benjamin Misselwitz Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials
Protocol of a monocentric, double-blind, randomized, superiority, controlled trial evaluating the effect of in-prison OROS-methylphenidate vs. placebo treatment in detained people with attention-deficit hyperactivity disorder (BATIR)
This study is a phase III, double-blinded, randomized, superiority, controlled trial of OROS-MPHvs. placebo. After randomization, the participants will receive 3 months of treatment with OROS-MPH or placebo (1:1 ratio) while incarcerated. Upon release, all participants will be offered the treatment (OROS-MPH) for 1 year but will remain blinded to their initial study group. The study will be conducted at the Division of Prison Health, Geneva, Switzerland, among incarcerated men (n = 150). Measures will include (1) investigator-rated ADHD symptoms, (2) acute events collected by the medical and prison teams, (3) assessment of...
Source: Trials - January 4, 2024 Category: Research Source Type: clinical trials
